coagulation factor Xa inhibitor
Jump to navigation
Jump to search
Indications
- prophylaxis for venous thromboembolism after joint replacement (total knee arthroplasty)
- treatment of deep vein thrombosis, venous thromboembolism, pulmonary embolism
Dosage
Adverse effects
Bleeding: andexanet reverses factor Xa inhibition
More general terms
More specific terms
Additional terms
References
- ↑ Journal Watch Oncology and Hematology June 5, 2012 Preventing Venous Thromboembolism After Joint Replacement Massachusetts Medical Society http://www.jwatch.org (Subsscription required
- ↑ 2.0 2.1 Lu G et al. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nat Med 2013 Apr; 19:446 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23455714
Ansell J. Blocking bleeding: Reversing anticoagulant therapy. Nat Med 2013 Apr; 19:402 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23558624 <Internet> http://www.nature.com/nm/journal/v19/n4/full/nm.3157.html